Anne Wojcicki is the founder and CEO of the 23andMe Research Institute. She is committed to putting individuals at the center of their health information and decisions with choice and transparency, and in turn empowering them to participate in research. Anne co-founded 23andMe, Inc. in 2006, three years after the first human genome was sequenced. Her goal was to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process.

Prior to founding 23andMe, Anne spent a decade on Wall Street investing in healthcare and felt frustrated by a system built around monetizing illness instead of incentivizing prevention. Anne's vision and persistence powered an industry-first community approach to genetic research. This novel, web-based research model has resulted in thousands of new genetic discoveries and brought personalized medicine to millions of people.